| Literature DB >> 32324239 |
Yassine Ochen1,2,3, Jesse Peek1,2, Detlef van der Velde4, Frank J P Beeres5, Mark van Heijl2,6, Rolf H H Groenwold3, R Marijn Houwert2, Marilyn Heng1.
Abstract
Importance: No consensus has been reached to date regarding the optimal treatment for distal radius fractures. The international rate of operative treatment has been increasing, despite higher costs and limited functional outcome evidence to support this shift.Entities:
Mesh:
Year: 2020 PMID: 32324239 PMCID: PMC7180423 DOI: 10.1001/jamanetworkopen.2020.3497
Source DB: PubMed Journal: JAMA Netw Open ISSN: 2574-3805
Baseline Characteristics of Included Studies in a Meta-analysis of Distal Radius Fractures
| Study | Study period | Design | Country | No. of participants | Treatment group, No. of participants | Age group, y | Mean age by treatment group, y | Male participants by treatment group, No. (%) | Mean follow-up by treatment group, mo | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operative | Nonoperative | Operative | Nonoperative | Operative | Nonoperative | Operative | Nonoperative | ||||||
| Abbaszadegan et al,[ | NA | RCT | Sweden | 47 | 23 | 24 | >18 | 63 (range, 22-75) | 11 (23.4) | 12 | |||
| Arora et al,[ | 2005-2008 | RCT | Austria | 73 | 36 | 37 | >65 | 75.9 (range, 65-88) | 77.4 (range, 65-89) | 8 (22.2) | 10 (27.0) | 12 | |
| Azzopardi et al,[ | 1997-2000 | RCT | Scotland | 54 | 27 | 27 | >60 | 72 (SD, 8) | 71 (SD, 9) | 4 (14.8) | 2 (7.4) | 12 | |
| Bartl et al,[ | 2008-2012 | RCT | Germany | 149 | 68 | 81 | >65 | 75.3 (SD, 6.7) | 74.4 (SD, 7.1) | 9 (13.2) | 12 (14.8) | 12 | |
| Martinez-Mendez et al,[ | 2012-2015 | RCT | Spain | 97 | 50 | 47 | >60 | 67 (SD, 8) | 70 (SD, 7) | 11 (22.0) | 10 (21.3) | 29 (range, 24-48) | |
| Mulders et al,[ | 2013-2016 | RCT | The Netherlands | 92 | 48 | 44 | 18-75 | 59 (IQR, 42-66) | 60 (IQR, 52-65) | 16 (33.3) | 7 (15.9) | 12 | |
| Sharma et al,[ | 2009-2010 | RCT | India | 64 | 32 | 32 | 22-55 | 52.4 (SD, 9.1) | 48.1 (SD, 10.3) | 12 (37.5) | 14 (43.8) | 24 | |
| Sirniö et al,[ | 2008-2014 | RCT | Finland | 80 | 38 | 42 | >50 | 62 (range, 50-79) | 64 (range, 50-82) | 1 (2.6) | 3 (7.1) | 24 | |
| Aktekin et al,[ | NA | RCS | Turkey | 46 | 22 | 24 | >65 | 69.8 (SD, 4.5) | 71.2 (SD, 5.2) | 9 (40.9) | 5 (20.8) | 27 (SD, 10.9) | 23 (SD, 11.0) |
| Alm-Paulsen et al,[ | 1997-2006 | RCS | Norway | 60 | 30 | 30 | 30-85 | 61 (range, 37-80) | 60 (range, 34-78) | NA | NA | 72 (range, 36-84) | 84 (range, 36-156) |
| Arora et al,[ | 2000-2005 | RCS | Austria | 114 | 53 | 61 | >70 | 75.9 (SD, 4.8) | 80.9 (SD, 5.7) | 17 (32.1) | 19 (31.1) | 52 (range, 12-64) | 62 (range, 12-81) |
| Barai et al,[ | 2014-2015 | RCS | New Zealand | 116 | 29 | 87 | >18 | 58 (IQR, 47-70) | 56 (IQR, 29-68) | 10 (34.5) | 25 (28.7) | 18 | |
| Chan et al,[ | 2009-2010 | PCS | Singapore | 75 | 40 | 35 | >65 | 71.5 (SD, 5.2) | 75.8 (SD, 9.3) | 6 (15.0) | 5 (14.3) | 12 | |
| Egol et al,[ | 2004-2008 | RCS | United States | 90 | 44 | 46 | >65 | 73 (SD, 6.2) | 76 (SD, 7.0) | 8 (18.2) | 6 (13.0) | 12 | |
| Gong et al,[ | 2008-2009 | PCS | South Korea | 50 | 26 | 24 | >18 | 53 (SD, 13) | 58 (SD, 13) | 6 (23.1) | 3 (12.5) | 6 | |
| Hung et al,[ | 2010-2013 | RCS | China | 57 | 26 | 31 | 61-80 | 65 (range, 61-80) | 64 (range, 61-80) | 5 (19.2) | 7 (22.6) | 12 (range, 6-24) | |
| Jordan et al,[ | 2011-2013 | RCS | United Kingdom | 159 | 74 | 85 | >50 | 66.3 (SD, 10.7) | 68.7 (SD, 11.8) | 12 (16.2) | 6 (7.1) | 24 (range, 17-36) | |
| Larouche et al,[ | NA | PCS | Canada | 129 | 70 | 59 | >55 | 64.6 (SD, 7.6) | 12 (9.3) | 12 | |||
| van Leerdam et al,[ | 2012 | RCS | Netherlands | 272 | 87 | 185 | >18 | 62 (SD, 16) | 69 (25.4) | 46 (SD, 4) | |||
| Lutz et al,[ | 1995-2011 | RCS | United Kingdom | 258 | 129 | 129 | >65 | 74 (SD, 5; range, 65-90) | 21 (8.1) | 11.3 (SD, 9.3) | 14.9 (SD, 8.9) | ||
| Tan et al,[ | 2006-2009 | RCS | United States | 63 | 31 | 32 | >18 | 65 (SD, 15) | 63 (SD, 18) | 2 (6.5) | 3 (9.4) | 13 (range, 12-17) | 14 (range, 11-23) |
| Toon et al,[ | 2011-2012 | RCS | Singapore | 60 | 32 | 28 | >21 | 52.1 (range, 23-77) | 57.4 (range, 26-79) | 14 (43.8) | 11 (39.3) | 12 | |
| Zengin et al,[ | 2014-2016 | RCS | Turkey | 49 | 25 | 24 | >60 | 66.6 (SD, 7.4) | 68.9 (SD, 8.7) | 7 (28.0) | 7 (29.2) | 16.5 (SD, 3.1) | 15.6 (SD, 4.4) |
Abbreviations: IQR, interquartile range; NA, not available; PCS, prospective cohort study; RCS, retrospective cohort study.
For studies that did not present characteristics for treatment groups separately, the numbers presented are for the overall study group, and the cells are merged.
Figure 1. Forest Plot of Medium-Term Disabilities of the Arm, Shoulder and Hand Questionnaire (DASH) Score
Medium term indicates 1 year or less. Results are reported using inverse-variance weighted random-effects methods. MD indicates mean difference; RCT, randomized clinical trial. Size of diamond markers indicates weight.
Figure 2. Forest Plot of Complication Rate of Distal Radius Fractures
Results are reported using inverse-variance weighted random-effects methods. RCT indicates randomized clinical trial; RR, risk raio. Size of diamond markers indicates weight.
Complications of Included Studies in a Meta-analysis of Distal Radius Fractures
| Complication classification | Incidence, No. (%) | |
|---|---|---|
| Operative group (n = 784) | Nonoperative group (n = 861) | |
| Infection | 25 (3.2) | 0 |
| Nerve injury or symptoms | 26 (3.3) | 57 (6.6) |
| Carpal tunnel syndrome | 8 (1.0) | 12 (1.4) |
| Chronic pain or CRPS | 21 (2.7) | 33 (3.8) |
| Tendon injury | 16 (2.0) | 4 (0.5) |
| Implant failure | 2 (0.3) | 0 |
| Wound dehiscence | 1 (0.1) | 0 |
| Tenosynovitis | 23 (2.9) | 4 (0.5) |
| Not specified or other | 22 (2.8) | 14 (1.6) |
| Malunion, nonunion, or malposition | 3 (0.4) | 23 (2.7) |
| Total | 147 (18.8) | 147 (17.1) |
Abbreviation: CRPS, complex regional pain syndrome.
Subgroup Analyses of Included Studies in a Meta-analysis of Distal Radius Fractures
| Subgroup | Medium-term DASH score | Complication rate | ||||||
|---|---|---|---|---|---|---|---|---|
| No. of studies | MD (95% CI) | No. of studies | RR (95% CI) | |||||
| All | 10 | −5.22 (−8.87 to −1.57) | .005 | 84 | 19 | 1.03 (0.69 to 1.55) | .87 | 62 |
| Studies only age ≥60 y | 4 | −0.98 (−3.52 to 1.57) | .45 | 34 | 10 | 1.51 (1.15 to 2.00) | .003 | 0 |
| Other studies age ≥18 y | 6 | −7.50 (−12.40 to −2.60) | .003 | 77 | 9 | 0.73 (0.39 to 1.38) | .34 | 60 |
| High-quality studies | 7 | −6.98 (−11.80 to −2.17) | .004 | 90 | 11 | 0.88 (0.50 to 1.55) | .66 | 64 |
| Study period 2008 or later | 6 | −5.31 (−10.20 to −0.43) | .03 | 87 | 10 | 0.72 (0.44 to 1.17) | .18 | 34 |
Abbreviations: DASH, Disabilities of the Arm, Shoulder and Hand questionnaire; MD, mean difference; RR, risk ratio.
Indicates heterogeneity.
Figure 3. Random-Effects Meta-regression Plot
Data are expressed as medium-term (≤1 year) Disabilities of the Arm, Shoulder and Hand questionnaire (DASH) score (operative vs nonoperative groups) according to mean age of the study population in a meta-analysis of distal radius fractures. Circles represent the different studies, with circle size corresponding to the study weight. The black line represents the null value. MD indicates mean difference.